Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Curis Inc
(NQ:
)
N/A
UNCHANGED
Last Price
Updated: 4:27 PM EDT, Jul 27, 2018
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
1.670
Today's Range
1.670 - 1.670
52wk Range
N/A - N/A
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
Curis Announces Effectiveness of 1-for-5 Reverse Stock Split
May 29, 2018
Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development and commercialization of innovative and effective therapeutics for the treatment of cancer, today announced that its...
From
PR Newswire
Curis Expands Senior Management Expertise with Appointment of Robert Martell, M.D., Ph.D., as Head of Research and Development
May 24, 2018
- Dr. David Tuck, CMO, to retire and return to academia -
From
PR Newswire
Performance
More News
Read More
Curis Announces 1-for-5 Reverse Stock Split
May 22, 2018
From
PR Newswire
Factors of Influence in 2018, Key Indicators and Opportunity within MSA Safety Incorporated, Curis, American States Water, AAC, eHealth, and Vista Gold — New Research Emphasizes Economic Growth
May 21, 2018
From
GlobeNewswire News Releases
Curis Reports First Quarter 2018 Financial Results
May 03, 2018
From
PR Newswire
Curis to Release First Quarter 2018 Financial Results and Hold Conference Call on May 3, 2018
April 26, 2018
From
PR Newswire
Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
April 06, 2018
From
PR Newswire
Investor Expectations to Drive Momentum within Atrion, Curis, Independence Contract Drilling, Utah Medical Products, FutureFuel, and Opiant Pharmaceuticals — Discovering Underlying Factors of Influenc
April 03, 2018
From
GlobeNewswire News Releases
Biotech Stocks' Research Reports Released on CorMedix, Curis, Cyclacel Pharma, and Cymabay Therapeutics
March 21, 2018
From
PR Newswire
Curis Reports Fourth Quarter and Year-End 2017 Financial Results
March 07, 2018
From
PR Newswire
Curis to Present at Cowen & Company 38th Annual Health Care Conference
March 04, 2018
From
PR Newswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.